Hepatitis B virus infection amongst pregnant women in North-eastern Nigeria- a call for action. 2011

A B Olokoba, and F K Salawu, and A Danburam, and L B Olokoba, and J K Midala, and L H Badung, and Awo Olatinwo
Department of Medicine, University of Ilorin Teaching Hospital, Ilorin, Nigeria. drabolokoba@yahoo.com

BACKGROUND It is well known that Hepatitis B virus infection is endemic in Nigeria. Even though studies have been carried out on Hepatitis B virus infection in different parts of Nigeria, and in different sub-groups of individuals, information regarding the prevalence of Hepatitis B virus infection in pregnant women is scanty especially from the North-eastern region of Nigeria. We therefore determined the seroprevalence of Hepatitis B surface antigen (HBsAg) amongst pregnant women in North Eastern Nigeria. METHODS A hospital-based cross-sectional study was carried out. The setting was the ante-natal clinic of the Federal Medical Centre, Yola, Nigeria. The duration of the study was from July 2008 to December 2008. Two hundred and thirty-one consecutively recruited pregnant women were screened for Hepatitis B surface antigen. Positive samples were re-tested using ELISA to eliminate false positives. Their biodata were obtained using a questionnaire to establish the presence of possible risk factors such as blood transfusion, surgery, etc. Written informed consent was obtained from each woman. RESULTS Out of the 231 pregnant women tested, nineteen of them were seropositive for Hepatitis B virus infection giving an infection rate of 8.2%. Women in the age group 25-29 years had the highest HBV infection rate. CONCLUSIONS This study confirms a high seroprevalence of Hepatitis B virus infect ion amongst pregnant women. It is recommended that pregnant women should be routinely screened for Hepatitis B virus infection as part of antenatal care services.

UI MeSH Term Description Entries
D009549 Nigeria A republic in western Africa, south of NIGER between BENIN and CAMEROON. Its capital is Abuja. Federal Republic of Nigeria
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011251 Pregnancy Complications, Infectious The co-occurrence of pregnancy and an INFECTION. The infection may precede or follow FERTILIZATION. Complications, Infectious Pregnancy,Infectious Pregnancy Complications,Maternal Sepsis,Pregnancy, Infectious Complications,Sepsis during Pregnancy,Sepsis in Pregnancy,Infectious Pregnancy Complication,Pregnancy Complication, Infectious,Sepsis in Pregnancies,Sepsis, Maternal
D011295 Prenatal Care Care provided the pregnant woman in order to prevent complications, and decrease the incidence of maternal and prenatal mortality. Antenatal Care,Care, Antenatal,Care, Prenatal
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B

Related Publications

A B Olokoba, and F K Salawu, and A Danburam, and L B Olokoba, and J K Midala, and L H Badung, and Awo Olatinwo
August 2010, Acta obstetricia et gynecologica Scandinavica,
A B Olokoba, and F K Salawu, and A Danburam, and L B Olokoba, and J K Midala, and L H Badung, and Awo Olatinwo
January 2020, Annals of African medicine,
A B Olokoba, and F K Salawu, and A Danburam, and L B Olokoba, and J K Midala, and L H Badung, and Awo Olatinwo
September 1994, East African medical journal,
A B Olokoba, and F K Salawu, and A Danburam, and L B Olokoba, and J K Midala, and L H Badung, and Awo Olatinwo
March 1998, The Southeast Asian journal of tropical medicine and public health,
A B Olokoba, and F K Salawu, and A Danburam, and L B Olokoba, and J K Midala, and L H Badung, and Awo Olatinwo
March 2019, BMC infectious diseases,
A B Olokoba, and F K Salawu, and A Danburam, and L B Olokoba, and J K Midala, and L H Badung, and Awo Olatinwo
January 2021, Journal of environmental and public health,
A B Olokoba, and F K Salawu, and A Danburam, and L B Olokoba, and J K Midala, and L H Badung, and Awo Olatinwo
January 2012, Nigerian journal of clinical practice,
A B Olokoba, and F K Salawu, and A Danburam, and L B Olokoba, and J K Midala, and L H Badung, and Awo Olatinwo
January 2000, European journal of epidemiology,
A B Olokoba, and F K Salawu, and A Danburam, and L B Olokoba, and J K Midala, and L H Badung, and Awo Olatinwo
March 2012, East African medical journal,
A B Olokoba, and F K Salawu, and A Danburam, and L B Olokoba, and J K Midala, and L H Badung, and Awo Olatinwo
July 1992, Tropical and geographical medicine,
Copied contents to your clipboard!